成(cheng)(cheng)(cheng)都華(hua)神科(ke)(ke)(ke)技集團股份有(you)限(xian)公(gong)(gong)司[深(shen)圳證(zheng)券交易所股票代碼:000790,簡稱(cheng):華(hua)神科(ke)(ke)(ke)技],始創(chuang)于(yu)1988年,華(hua)神科(ke)(ke)(ke)技起源(yuan)于(yu)成(cheng)(cheng)(cheng)都中(zhong)(zhong)醫(yi)藥(yao)(yao)(yao)大學(xue)附屬制(zhi)(zhi)藥(yao)(yao)(yao)廠,是(shi)以現代中(zhong)(zhong)藥(yao)(yao)(yao)、生物(wu)制(zhi)(zhi)藥(yao)(yao)(yao)、中(zhong)(zhong)醫(yi)連鎖、醫(yi)美、全(quan)(quan)周(zhou)期(qi)生命養護為主營業務的大健康全(quan)(quan)產業鏈國家重(zhong)點高新(xin)技術(shu)企業。華(hua)神科(ke)(ke)(ke)技由華(hua)神科(ke)(ke)(ke)技集團制(zhi)(zhi)藥(yao)(yao)(yao)廠、成(cheng)(cheng)(cheng)都華(hua)神艾草科(ke)(ke)(ke)技有(you)限(xian)公(gong)(gong)司、成(cheng)(cheng)(cheng)都中(zhong)(zhong)醫(yi)藥(yao)(yao)(yao)大學(xue)華(hua)神藥(yao)(yao)(yao)業有(you)限(xian)責(ze)任(ren)(ren)公(gong)(gong)司、成(cheng)(cheng)(cheng)都華(hua)神生物(wu)技術(shu)有(you)限(xian)責(ze)任(ren)(ren)公(gong)(gong)司以及四川華(hua)神鋼構有(you)限(xian)責(ze)任(ren)(ren)公(gong)(gong)司等全(quan)(quan)資或控股子公(gong)(gong)司組成(cheng)(cheng)(cheng),員工近1200人。
華神科(ke)(ke)(ke)技(ji)(ji)依托(tuo)“國(guo)家(jia)(jia)級企業技(ji)(ji)術中(zhong)心”和(he)“博士后科(ke)(ke)(ke)研(yan)工作(zuo)站(zhan)”等(deng)重點資源及融合平(ping)臺,與(yu)包括四川(chuan)大學(xue)(xue)、成都中(zhong)醫藥大學(xue)(xue)在內的(de)(de)(de)國(guo)內外(wai)數十所高(gao)等(deng)院(yuan)校、科(ke)(ke)(ke)研(yan)院(yuan)所及知名醫院(yuan)建立(li)了(le)(le)開放(fang)式的(de)(de)(de)、互利共贏的(de)(de)(de)“產、學(xue)(xue)、研(yan)”一(yi)體(ti)化合作(zuo)平(ping)臺。華神科(ke)(ke)(ke)技(ji)(ji)先后承擔了(le)(le)國(guo)家(jia)(jia)、省、市重大科(ke)(ke)(ke)研(yan)項(xiang)(xiang)(xiang)目(mu)50余項(xiang)(xiang)(xiang),共獲得國(guo)際、國(guo)內發明專(zhuan)(zhuan)(zhuan)利100余項(xiang)(xiang)(xiang),共獲得省部(bu)級以上科(ke)(ke)(ke)技(ji)(ji)進步獎10項(xiang)(xiang)(xiang)。其中(zhong)包括授權國(guo)際專(zhuan)(zhuan)(zhuan)利3項(xiang)(xiang)(xiang),分(fen)別含德國(guo)、法(fa)國(guo)、意大利、荷蘭(lan)、英國(guo)5個國(guo)家(jia)(jia)專(zhuan)(zhuan)(zhuan)利,為集團(tuan)的(de)(de)(de)發展提供了(le)(le)強(qiang)大的(de)(de)(de)技(ji)(ji)術、項(xiang)(xiang)(xiang)目(mu)支撐與(yu)創(chuang)新(xin)賦(fu)能(neng)。